Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haye H van der Wal

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Circulation|May 21, 2019
Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart FailurePeter van der Meer, Haye H van der Wal, Vojtech Melenovsky
European Journal of Heart Failure|December 10, 2015
Sleep-disordered breathing and chronic heart failure: changing position may be importantHaye H van der Wal, Martin R Cowie, Peter van der Meer
Journal of Cardiac Failure|December 22, 2015
Response: A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff?Grietje E de Vries, Haye H van der Wal, Peter Wijkstra, et al.
Handbook of Experimental Pharmacology|April 7, 2017
Comorbidities in Heart FailureHaye H van der Wal, Vincent M van Deursen, Peter van der Meer, et al.
Journal of Cardiac Failure|May 14, 2026
Proton-pump inhibitor use as a modifiable etiological factor for iron deficiency in heart failureMats Kutscher, Haye H van der Wal, Adriaan A Voors, et al.
Expert Opinion on Pharmacotherapy|June 3, 2016
Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemiaHaye H van der Wal, Niels Grote Beverborg, Dirk J van Veldhuisen, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Genetically Determined High Levels of Iron Parameters Are Protective for Coronary Artery DiseaseNiels Grote Beverborg, M Abdullah Said, Haye H van der Wal, et al.
JAMA Cardiology|June 13, 2019
Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF StudiesNiels Grote Beverborg, Haye H van der Wal, IJsbrand T Klip, et al.
European Heart Journal|September 27, 2019
Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet useHaye H van der Wal, Niels Grote Beverborg, Kenneth Dickstein, et al.
European Journal of Heart Failure|April 4, 2020
Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failureHaye H van der Wal, Niels Grote Beverborg, Jozine M Ter Maaten, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Circulation|May 21, 2019
Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart FailurePeter van der Meer, Haye H van der Wal, Vojtech Melenovsky
European Journal of Heart Failure|December 10, 2015
Sleep-disordered breathing and chronic heart failure: changing position may be importantHaye H van der Wal, Martin R Cowie, Peter van der Meer
Journal of Cardiac Failure|December 22, 2015
Response: A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff?Grietje E de Vries, Haye H van der Wal, Peter Wijkstra, et al.
Handbook of Experimental Pharmacology|April 7, 2017
Comorbidities in Heart FailureHaye H van der Wal, Vincent M van Deursen, Peter van der Meer, et al.
Journal of Cardiac Failure|May 14, 2026
Proton-pump inhibitor use as a modifiable etiological factor for iron deficiency in heart failureMats Kutscher, Haye H van der Wal, Adriaan A Voors, et al.
Expert Opinion on Pharmacotherapy|June 3, 2016
Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemiaHaye H van der Wal, Niels Grote Beverborg, Dirk J van Veldhuisen, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Genetically Determined High Levels of Iron Parameters Are Protective for Coronary Artery DiseaseNiels Grote Beverborg, M Abdullah Said, Haye H van der Wal, et al.
JAMA Cardiology|June 13, 2019
Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF StudiesNiels Grote Beverborg, Haye H van der Wal, IJsbrand T Klip, et al.
European Heart Journal|September 27, 2019
Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet useHaye H van der Wal, Niels Grote Beverborg, Kenneth Dickstein, et al.
European Journal of Heart Failure|April 4, 2020
Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failureHaye H van der Wal, Niels Grote Beverborg, Jozine M Ter Maaten, et al.
Pageof 3